Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Celumigen Pharmaceuticals logo — company profile

Celumigen Pharmaceuticals

Founded 2013 United States Los Angeles, United States 2-10 employees Biotechnology, Health Care +1

General Information

Company Name Celumigen Pharmaceuticals
Founded Year 2013
Location United States Los Angeles, United States +1
Employees 2-10
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when Celumigen Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Celumigen Pharmaceuticals

Celumigen Pharmaceuticals is a biotechnology startup based in the United States, founded in 2013. The company specializes in developing innovative prescription treatments and novel drug delivery systems for various skin conditions and diseases. Celumigen's flagship product is a patented 505 (b) (2) treatment that targets multiple indications in cutaneous viral diseases, aiming to address the significant unmet needs of a large patient population. With a focus on the biotechnology, healthcare, and pharmaceutical industries, Celumigen Pharmaceuticals presents an exciting investment opportunity in the rapidly evolving healthcare sector. With its groundbreaking approach to addressing skin-related ailments, the company is positioned to make a significant impact in the field of dermatological treatments.

No funding data available for Celumigen Pharmaceuticals yet.

Get notified when Celumigen Pharmaceuticals raises funding

Celumigen Pharmaceuticals Alternatives & Competitors

Celumigen Pharmaceuticals vs
Gismo Therapeutics Inc.
Gismo Therapeutics Inc.

Pioneering advanced treatments for Alzheimer’s and Parkinson’s diseases since 2013.

Grant
6 employees
Biotechnology, Health Care
Celumigen Pharmaceuticals vs
APRINOIA Therapeutics
APRINOIA Therapeutics

Aprinoia Therapeutics is dedicated to establish a drug discovery and early development company that...

Series Unknown
24 employees
Biotechnology, Health Care
Celumigen Pharmaceuticals vs
IBI-Ag
IBI-Ag Israel

Unleashing the economic value of Bioinsecticides for a Sustainable Food Supply

Seed
12 employees
Biotechnology

FAQ About Celumigen Pharmaceuticals

Celumigen Pharmaceuticals develops innovative prescription treatments and novel drug delivery systems for conditions and diseases of the skin. Our novel, patented 505 (b) (2) treatment is targeting multiple indications in cutaneous viral disease, each one representing a large patient population with...
Celumigen Pharmaceuticals was founded in 2013.
Celumigen Pharmaceuticals is headquartered in Los Angeles, United States.
Celumigen Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Celumigen Pharmaceuticals has approximately 2-10 employees.
Top alternatives and competitors to Celumigen Pharmaceuticals include Gismo Therapeutics Inc., APRINOIA Therapeutics, IBI-Ag, PATH EX, Inc., AVMBioMed. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Celumigen Pharmaceuticals and Gismo Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Celumigen Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy